Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Men of all racial and ethnic groups 18 years of age or older
• Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
• Prior participation on clinical trials is allowed
Locations
United States
California
Los Angeles General Medical Center
RECRUITING
Los Angeles
USC / Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Contact Information
Primary
Cheryl Kefauver, RN
Cheryl.Kefauver@med.usc.edu
323-865-0459
Time Frame
Start Date: 2023-02-21
Estimated Completion Date: 2027-02-21
Participants
Target number of participants: 300
Treatments
Observational
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
Related Therapeutic Areas
Sponsors
Leads: University of Southern California
Collaborators: National Cancer Institute (NCI)